Tim Demuth - 13 May 2022 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PVLA)

Role
Chief Medical Officer
Signature
/s/ Ahmed Mousa, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
13 May 2022
Net transactions value
+$10,260
Form type
4
Filing time
16 May 2022, 20:19:05 UTC
Previous filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PIRS Common Stock Purchase $10,260 +6,000 $1.71* 6,000 13 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Purchase price was 1.65 Euros per share which was converted into dollars using the noon buying rate of 1.00 Euro to $1.03745 based on information provided on May 13, 2022 via Xignite.